NS1 Antigen combo rapid Test kit

Name: China cheap Aids Dengue IgG/IgM/NS1 Antigen combo rapid Test kit
Brand: HangZhou Testsea biotechnology Co., Ltd.
SKU: 1963930341

Zhejiang, ChinaHangZhou Testsea biotechnology Co., Ltd.

US$0.10-2.00

1,000 Pieces

Sample price:US$0.00/piece.Request sample

Product profile

Customization

Available

Type

IVD rapid test kits

Application

Initial screening for hbsag infection

Model NO.

101012

OEM

Available

Certificate

ISO 13485;MSDS

MOQ

1000PCS

Package

40T

Specimen

WB/S/P

Shelf Life

24 Months

Storage

4-30

Format

Cassette / Strip

Procedure

Fast d easy to use

Price

Factory

Transport Package

Box

Specification

25/40 Tests/Box

Trademark

Testsealabs

Origin

China

Production Capacity

5000000PCS Per Month

Company profile

HangZhou Testsea biotechnology Co., Ltd.

Zhejiang, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2022-04-08Nearest Port: Shanghai, Ningbo, ShenzhenAverage Response Time: ≤9.63h CertifiedTerms of Payment: LC, T/T, D/P

AI-Powered supplier vetting

SummaryTestsea Biotechnology, based in Hangzhou, China, is a company founded in 2015 specializing in the R&D, production, and sale of in vitro diagnostic and veterinary products. The company holds ISO 9001 and GMP certifications, indicating robust quality management systems. With over 10 production lines and an annual production output between US$50 million and US$100 million, Testsea demonstrates substantial production capability. The company exports extensively, with 90% of sales derived from international markets. Testsea emphasizes innovation through its development of core technologies for diagnostic testing and offers a wide range of rapid test products.

Supplier typeTestsea Biotechnology is a trading company and manufacturer/factory based in Zhejiang, China.

CertificationsThe company holds ISO 9001 and GMP certifications, indicating adherence to quality management standards.

R&D capabilityThe company focuses on R&D and has built detection platforms, indicating strong innovation capabilities.

Production capacityWith over 10 production lines and an annual output of US$50M - US$100M, the company has substantial production capacity.

Client casesThe company's products are used globally in over 100 countries for various rapid diagnostic applications.